QPS LLC

QPS LLC specializes in preclinical biotechnology research and analytical laboratory services supporting non-clinical drug development programs. The company delivers advanced pharmacokinetic and pharmacodynamic studies using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify biomarkers and drug metabolites in complex biological matrices, particularly in non-human primate models of infectious disease. Their technical expertise centers on assay validation, sample processing, and data integrity for non-GLP and GLP-aligned studies, with a demonstrated focus on sepsis and inflammatory pathway biomarkers such as R406 and R940406. QPS differentiates itself through precision analytical workflows tailored to translational research needs, enabling rapid data generation for early-phase therapeutic candidates. The contractor maintains a consistent partnership with the Department of Health and Human Services, delivering critical laboratory testing and bioresearch services across multiple HHS components, including the National Heart, Lung, and Blood Institute. Their work supports immune response characterization, pharmacokinetic modeling, and biomarker validation in preclinical models, aligning closely with HHS priorities in infectious disease therapeutics and translational science. QPS operates primarily within NAICS 541714 (biotechnology research and development) and 541380 (testing laboratories), positioning itself as a niche provider of specialized bioanalytical services for government-funded biomedical research. The firm focuses on the intersection of pharmacology, analytical chemistry, and preclinical model systems, serving the biopharmaceutical development pipeline through contract research that bridges discovery and regulatory submission readiness. As a small business entity structured as a 2K (small business under the SBA’s 8(a) program definition), QPS LLC is headquartered in Newark, Delaware, with no public certifications beyond its small business status. Its geographic footprint is centered in the Mid-Atlantic region, with operations optimized to support federal research initiatives requiring rapid, high-fidelity analytical output in controlled laboratory environments.